BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 15936443)

  • 1. Cosmetic oculofacial applications of botulinum toxin: a report by the American Academy of Ophthalmology.
    Kaltreider SA; Kennedy RH; Woog JJ; Bradley EA; Custer PL; Meyer DR; ;
    Ophthalmology; 2005 Jun; 112(6):1159-67. PubMed ID: 15936443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cosmetic applications of botulinum toxin in oculofacial region.
    Sarić D
    Acta Clin Croat; 2010 Dec; 49(4):525-8. PubMed ID: 21830467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cosmetic upper-facial rejuvenation with botulinum.
    Ellis DA; Tan AK
    J Otolaryngol; 1997 Apr; 26(2):92-6. PubMed ID: 9106083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of 3- and 5-injection patterns (30 and 50 U) of botulinum toxin A (Dysport) for the treatment of wrinkles in the glabella and the central forehead region.
    Rzany B; Ascher B; Fratila A; Monheit GD; Talarico S; Sterry W
    Arch Dermatol; 2006 Mar; 142(3):320-6. PubMed ID: 16549707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum toxin A: a review of 1,085 oral and maxillofacial patient treatments.
    Niamtu J
    J Oral Maxillofac Surg; 2003 Mar; 61(3):317-24. PubMed ID: 12618971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding botulinum toxin. Surgical anatomy of the frown, forehead, and periocular region.
    Wieder JM; Moy RL
    Dermatol Surg; 1998 Nov; 24(11):1172-4. PubMed ID: 9834734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary and adjunctive uses of botulinum toxin type A in the periorbital region.
    Balikian RV; Zimbler MS
    Facial Plast Surg Clin North Am; 2005 Nov; 13(4):583-90, vii. PubMed ID: 16253845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Facial rejuvenation using botulinum toxin A: review and updates.
    Vartanian AJ; Dayan SH
    Facial Plast Surg; 2004 Feb; 20(1):11-9. PubMed ID: 15034809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient-reported outcomes with botulinum toxin type A treatment of glabellar rhytids: a double-blind, randomized, placebo-controlled study.
    Fagien S; Cox SE; Finn JC; Werschler WP; Kowalski JW
    Dermatol Surg; 2007 Jan; 33(1 Spec No.):S2-9. PubMed ID: 17241410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clostridium botulinum type A toxin for the treatment of upper face animation lines: an Iranian experience.
    Farahvash MR; Arad S
    J Cosmet Dermatol; 2007 Sep; 6(3):152-8. PubMed ID: 17760691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum toxins for facial wrinkles: beyond glabellar lines.
    Dayan SH; Maas CS
    Facial Plast Surg Clin North Am; 2007 Feb; 15(1):41-9, vi. PubMed ID: 17317554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 'Nefertiti lift': a new technique for specific re-contouring of the jawline.
    Levy PM
    J Cosmet Laser Ther; 2007 Dec; 9(4):249-52. PubMed ID: 18236245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of botulinum toxin type A in cosmetic facial procedures.
    Jaspers GW; Pijpe J; Jansma J
    Int J Oral Maxillofac Surg; 2011 Feb; 40(2):127-33. PubMed ID: 20965695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complications of botulinum toxin A use in facial rejuvenation.
    Vartanian AJ; Dayan SH
    Facial Plast Surg Clin North Am; 2003 Nov; 11(4):483-92. PubMed ID: 15062253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum toxin in aesthetic applications: 'how often misused words generate misleading thoughts'. (Response to: De Boulle K. Patient satisfaction with different botulinum toxin type A formulations in the treatment of moderate to severe upper facial rhytids. J Cosmet Laser Ther. 2008;10:87-92).
    Pickett A; Rzany B
    J Cosmet Laser Ther; 2009 Sep; 11(3):178-9; author reply 180-1. PubMed ID: 19337943
    [No Abstract]   [Full Text] [Related]  

  • 16. Botulinum toxin type a injection for lateral canthal rhytids : effect on tear film stability and tear production.
    Ho MC; Hsu WC; Hsieh YT
    JAMA Ophthalmol; 2014 Mar; 132(3):332-7. PubMed ID: 24385079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prevention and management of locoregional complications of botulinum A toxin injections in cosmetic treatment].
    Gassia V
    Ann Dermatol Venereol; 2009 May; 136 Suppl 4():S146-51. PubMed ID: 19576482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of Botox to treat glabellar rhytids.
    Bassichis BA; Thomas JR
    Facial Plast Surg Clin North Am; 2005 Feb; 13(1):11-4. PubMed ID: 15519924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy and safety of a new U.S. Botulinum toxin type A in the retreatment of glabellar lines following open-label treatment.
    Rubin MG; Dover J; Glogau RG; Goldberg DJ; Goldman MP; Schlessinger J
    J Drugs Dermatol; 2009 May; 8(5):439-44. PubMed ID: 19537366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum toxin, immunologic considerations with long-term repeated use, with emphasis on cosmetic applications.
    Borodic G
    Facial Plast Surg Clin North Am; 2007 Feb; 15(1):11-6, v. PubMed ID: 17317551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.